WHO adds first mpox vaccine to prequalification list
The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex The World Health Organization (WHO) has announced that...
The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex The World Health Organization (WHO) has announced that...
GlobalData emphasises importance of Improved clinical trials World Sepsis Day, observed annually on 13 September, aims to raise awareness about...
Innovative immunotherapy drug HTL0039732 shows potential in trials Nxera Pharma and Cancer Research UK are set to present their ongoing...
New study highlights potential benefits of menopausal hormone therapy A recent study published in the American Journal of Psychiatry suggests...
Promising results for novel orexin agonist in sleep-deprived volunteers Nxera Pharma, formerly known as Sosei Group, has announced that its...
Patients with relapsed multiple myeloma gain access to life-extending therapy The Scottish Medicines Consortium (SMC) has approved Tecvayli – also...
New evidence highlights AI’s potential in early lung cancer detection At the IASLC 2024 World Conference on Lung Cancer in...
Molecular imaging agent 99mTc-maraciclatide to aid in disease prognostication Serac Healthcare, a clinical radiopharmaceutical company, and the University of Exeter...
Critically ill individuals will benefit from futuristic tech APL, one of Sweden’s largest manufacturers of extemporaneous medicines and a leading...
Research suggests that LLMs could be used to support trainee doctors, nurses and GPs The chatbot ChatGPT performed better than...
New treatment could simplify diabetes management for millions Eli Lilly and Company has announced promising results from two phase 3...
New biomarker test aims to improve early-stage melanoma treatment AMLo Biosciences has announced the successful receipt of the UKCA mark...
Pre-clinical data of VTX-806 in demonstrated normalisation of metabolic parameters Vivet Therapeutics, a clinical-stage biotech company developing novel gene therapies...
However the company will not continue developing the candidate Acelyrin has shared positive results from a late-stage study of its...
The partnership will improve care for patients with pancreatic cancer myTomorrows, a global health technology company connecting patients with all...
Over 135,000 people have signed a petition to prioritise a national screening programme The charity Prostate Cancer Research (PCR) has...
The spread of multiple bacteria could be tracked simultaneously through sequencing method Using a genomic approach, researchers have developed a...
200,000 people in the UK have what is considered a ‘hidden’ lung condition Bronchiectasis is the third most common lung...
The grant will support clinical trials of rare disease therapy for leukodystrophy Oxford-based SynaptixBio has been awarded a £2m BioMedical...
The new test takes an average of 13 hours to identify the correct treatment compared to several days with current...